SUZ12 Antibody
-
货号:CSB-PA621859LA01HU
-
规格:¥440
-
促销:
-
图片:
-
Western Blot
Positive WB detected in: Rat kidney tissue, Rat liver tissue
All lanes: SUZ12 antibody at 3.4μg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 84 kDa
Observed band size: 84 kDa -
IHC image of CSB-PA621859LA01HU diluted at 1:1000 and staining in paraffin-embedded human kidney tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
-
Immunofluorescence staining of HepG2 cells with CSB-PA621859LA01HU at 1:333, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
-
-
其他:
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) SUZ12 Polyclonal antibody
-
Uniprot No.:Q15022
-
基因名:SUZ12
-
别名:ChET 9 protein antibody; CHET9 antibody; Chromatin precipitated E2F target 9 protein antibody; JJAZ1 antibody; Joined to JAZF1 protein antibody; KIAA0160 antibody; Polycomb protein SUZ12 antibody; Suppressor of zeste 12 homolog antibody; Suppressor of zeste 12 protein homolog antibody; SUZ12 antibody; SUZ12 polycomb repressive complex 2 subunit antibody; SUZ12_HUMAN antibody
-
宿主:Rabbit
-
反应种属:Human, Rat
-
免疫原:Recombinant Human Polycomb protein SUZ12 protein (131-305AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
本页面中的产品,SUZ12 Antibody (CSB-PA621859LA01HU),的标记方式是Non-conjugated。对于SUZ12 Antibody,我们还提供其他标记。见下表:
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:>95%, Protein G purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, WB, IHC, IF
-
推荐稀释比:
Application Recommended Dilution WB 1:500-1:5000 IHC 1:1000-1:2000 IF 1:50-1:500 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:Polycomb group (PcG) protein. Component of the PRC2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. The PRC2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2 complex include HOXC8, HOXA9, MYT1 and CDKN2A.
-
基因功能参考文献:
- Functional assays to reveal the targets of n-miR-G665 showed that polycomb protein Suz12 is regulated by n-miR-G665, which in turn regulates the expression of n-miR-G665 through feedback loop mechanism. PMID: 29379063
- Data suggest the polycomb repressive complex 2 subunits EZH2, SUZ12, and EED protein axis as promising therapeutic target for treating sarcoma. PMID: 29415665
- High SUZ12 expression is associated with invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma. PMID: 27582550
- we analyzed eight probands with clinically suspected Weaver syndrome by whole-exome sequencing and identified three mutations: a 25.4-kb deletion partially involving EZH2 and CUL1 ,a missense mutation , and a missense mutation in SUZ12 inherited from her father .In vitro functional analyses demonstrated that the identified EED and SUZ12 missense mutations cause decreased decreased trimethylation of lysine 27 of H3 PMID: 28229514
- PRE-PIK3C2B interacts directly with YY1 in vitro and recruits PRC2 complex in vivo. The localization of PcG proteins including YY1 to PRE-PIK3C2B in HEK cells is decreased on knock-down of either YY1 or SUZ12. PMID: 23805300
- EZH1, SUZ12 and UXT work synergistically to regulate pathway activation in the nucleus. PMID: 27127229
- Mutation in the SUZ12 gene is associated with malignant peripheral nerve sheath tumors. PMID: 28124441
- Overexpression of miR-105 inhibited cell proliferation, tumorigenesis, migration, invasion, and drug sensitivity, whereas overexpression of suppressor of Zeste 12 homolog antagonized the tumor-suppressive functions of miR-105. PMID: 28618952
- Mutations of SUZ12 and EED are reported to have tumor suppressive functions. (Review) PMID: 27000413
- The difference in the SUZ12 and CBX8 genes expression were significantly divergent between tumors and their marginal tissues. PMID: 26837964
- Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer PMID: 26268246
- Data show that RAS protein activation was the initiating oncogenic event, with polycomb repressive complex 2 (PRC2) subunits impairment being a secondary event. PMID: 26457648
- SUZ12 is a key molecule in the regulation of monoallelic expression of IGF2. PMID: 26407907
- Overexpression of Suz12 was associated with lung adenocarcinoma. PMID: 25279705
- found that expression of PcG proteins and H3K27me3 showed prognostic value in our study cohort PMID: 25243792
- this study described that miR-489 expression level was significantly reduced in lung cancer samples (n = 115) and cell lines. Abnormal expression of miR-489 regulated the cells invasion by binding SUZ12 3'-UTR in vitro. PMID: 25833694
- downregulation of SUZ12 and ZNF198 leads to epigenetic reprogramming of infected hepatocytes. Because both Plk1 and HOTAIR are elevated in many human cancers, we propose that their combined effects are involved in epigenetic reprogramming PMID: 25855382
- Conclude that the expression of SUZ12 is increased along with the degree of infiltration and metastasis of gastric carcinoma. PMID: 26176059
- Data show that overall enhancer of zeste 2 (EZH2), embryonic ectoderm development (EED) and suppressor of zeste 12 homolog (SUZ12) expression in the colorectal cancer (CRC) tissues was significantly increased than in the non-cancerous tissue. PMID: 25326896
- Somatic mutations of SUZ12 have a central role in malignant transformation of peripheral nerve sheath tumors. PMID: 25305755
- Polycomb repressive complex 2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. PMID: 25240281
- reduction in the total SUZ12 level was not a sufficient cause of the resolution of the epigenetic bivalency of beta-cell transcription factors in embryonic stem cells. PMID: 24845830
- malat1 promotes bladder cancer metastasis by associating with suz12. PMID: 24449823
- Data shows EZH2 or SUZ12 depletion leads to HP1 loss from chromatin and degradation. PMID: 25047840
- the polycomb group gene SUZ12 functions as tumour suppressor in peripheral nerve sheath tumors, high-grade gliomas and melanomas by cooperating with mutations in NF1 PMID: 25119042
- provide evidences suggesting that SUZ12 is an oncogene in non-small cell lung cancer PMID: 24633887
- postulate that this interparalog structural difference, together with low allelic recombination rates, could have caused a reduction in NAHGC between SUZ12 and SUZ12P during human evolution PMID: 24385046
- SUZ12 depletion mediated by RNA interference (RNAi) led to a reduction of gastric cell numbers and arrested the cell cycle at G1/S point. PMID: 23735840
- Polycomb Repressive Complex 2 overexpression is associated with small cell lung cancer. PMID: 23714854
- SUZ12 inactivation results in apoptosis in human colon cancer stem cells. PMID: 23588203
- SUZ12 promotes the proliferation of human EOC cells by inhibiting apoptosis and HRK is a novel SUZ12 target gene whose upregulation contributes to apoptosis induced by SUZ12 knockdown. PMID: 22964433
- studies suggest a tumor suppressor role for PRC2 in human leukemia and suggest a hitherto unrecognized dynamic interplay between oncogenic NOTCH1 and PRC2 function PMID: 22237151
- Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies. PMID: 22308284
- We propose Plk1 activity down-regulates ZNF198 and SUZ12, thereby enhancing both HBV replication and pX-mediated oncogenic transformation. PMID: 21480320
- Results support the hypothesis that the abnormal expression of SUZ12 accounts for some of the unexplained features of mantle cell lymphoma, such as abnormal DNA repair and increased resistance to apoptosis. PMID: 20558579
- histone modification including PRC2-mediated repressive histone marker H3K27me3 and active histone marker acH4 may involve in CD11b transcription during HL-60 leukemia cells reprogramming to terminal differentiation[polycomb repressive complex 2 ] PMID: 19578722
- Loss of miR-200 during CSC formation increases Suz12 expression, Suz12 binding, H3-K27 trimethylation, and Polycomb-mediated repression of the E-cadherin gene. PMID: 20832727
- SUZ12 blocks cell differentiation, as SUZ12 knockdown releases differentiation programs in a chronic myeloid blastic phase transformed cell line. PMID: 19847889
- Endometrial stromal tumors(ESTs) are genetically heterogeneous, with prevalence of JAZF1-JJAZ1 fusion highest among ESTs of classic histology. Diagnostic utility of JAZF1-JJAZ1 fusion transcript assay in ESTs may be limited to classic histologic subset. PMID: 15043312
- JJAZ1 gene recombination may have a role in mosaicism in neurofibromatosis type 1 PMID: 15257518
- Data show that SUZ12 is distributed across large portions of over two hundred genes encoding key developmental regulators. PMID: 16630818
- The JAZF1-JJAZ1 fusion is a frequent, although nonuniform, feature of endometrial stromal neoplasia. PMID: 17197920
- SUZ12 regulates H3-K9 methylation in an EZH2-independent fashion. Knockdown of SUZ12 in human cells caused a reduction in H3K27me3 and H3K9me3, and altered the distribution of HP1 alpha. PMID: 17406994
- The JAFZ1-JJAZ1 fusion gene is present in the endometrial stromal and smooth muscle components of endometrial stromal tumors. PMID: 17667554
- SUZ12, a component of the polycomb repressor complex 2, is recruited to the beta-globin gene. PMID: 17970752
- Both benign and malignant forms of endometrial stromal tumor have the JAZF1-JJAZ1 fusion, but only the malignant form also exhibits exclusion of the unrearranged JJAZ1 allele. PMID: 18077430
- the two PRC2 components SUZ12 and EZH2 are sumoylated in vitro and in vivo PMID: 18628979
- YY1 physically interacts with SUZ12 and can act as a mediator to recruit the polycomb group proteins and DNA methyltransferases to participate in the CEBPD gene silencing process PMID: 18753137
- study shows normal endometrial stromal cells contain a specific chimeric RNA joining 5' exons of JAZF1 gene on chromosome 7p15 to 3' exons of JJAZ1/SUZ12 gene on chromosome 17q11; this RNA is translated into JAZF1-JJAZ1 with anti-apoptotic activity PMID: 18772439
- The JAZF1-JJAZ1 gene fusion was not identified in any Uterine tumor resembling ovarian sex cord tumors PMID: 19542872
显示更多
收起更多
-
相关疾病:A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer.
-
亚细胞定位:Nucleus.
-
蛋白家族:VEFS (VRN2-EMF2-FIS2-SU(Z)12) family
-
组织特异性:Overexpressed in breast and colon cancer.
-
数据库链接:
HGNC: 17101
OMIM: 606245
KEGG: hsa:23512
STRING: 9606.ENSP00000316578
UniGene: Hs.462732
Most popular with customers
-
-
-
-
-
-
VDAC1 Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human, Mouse, Rat
-
-